# Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting

> **NCT06112028** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Yanbin Li** · enrollment: 200 (estimated)

## Conditions studied

- Stent Restenosis

## Interventions

- **DRUG:** Tongxinluo capsule
- **OTHER:** Primary therapy

## Key facts

- **NCT ID:** NCT06112028
- **Lead sponsor:** Yanbin Li
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-10
- **Primary completion:** 2025-11
- **Final completion:** 2026-11
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06112028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06112028, "Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06112028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*